Jiankai Liang

13PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 07, 2026
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1+CD8+ T cells.

|Jul 01, 2026
Alphavirus M1 disrupts super-enhancer-driven oncogenic transcription via non-structural protein NSP2 in osteosarcoma.

|Oct 06, 2025
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1.

Linyi Hu, Guigen Zhang, Yuan Lin

|Jul 03, 2025
Suppression of multiple mouse models of refractory malignancies by reprogramming IL-18 ligand-receptor interaction.

Zhen Fan, Ying Liu, Xueying Lin

|Oct 20, 2023
STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1.

Deli Song, Xudong Jia, Yuanzhu Gao

|Jun 09, 2023
Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile.

Li Guo, Cheng Hu, Yang Liu

Pageof 3

Frequent Collaborators

6 joint publications

Yuan Lin

5 joint publications

Wenbo Zhu

3 joint publications

Qinfen Zhang

2 joint publications

Xudong Jia